Amgen Set for 2025 Stelara Biosimilar Launch Post Settlement
Town of Cheyenne WellsCity · CO- Approved
- Feb 1, 2024
The 30-second brief
Amgen's biosimilar Wezlana will enter the market in 2025 following a settlement with Johnson & Johnson delaying generic competition for Stelara.
AMGEN holds this contract with Town of Cheyenne Wells. Its other public contracts on record include work for Conejo Academy of Leadership and Language Immersion and University Of Wisconsin-System Administration.
Term as filed: Launch of Wezlana biosimilar set for 2025 under deal with Johnson & Johnson.
See who signed off on this contract.
See who signed offFree account · 30-second setup · No credit card
Contract details
- Document date
- February 1, 2024
- Term
- Launch of Wezlana biosimilar set for 2025 under deal with Johnson & Johnson
- Vendor
- AMGEN
- Agency
- Town of Cheyenne Wells
- Source document
- accountableus_report_on_drug_patent_tactics.pdf (Report)
AMGEN's other public contracts
More Town of Cheyenne Wells contracts
Questions about this contract
Who was awarded the government contract by Town of Cheyenne Wells?
AMGEN was awarded this government contract by Town of Cheyenne Wells, as recorded on February 1, 2024.
What type of contract is this?
This is a government contract, documented as a report record.
Where was this contract approved?
This contract appears in accountableus_report_on_drug_patent_tactics.pdf (Report), dated February 1, 2024 from Town of Cheyenne Wells. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does AMGEN hold?
AMGEN may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is Town of Cheyenne Wells currently buying?
Explore Town of Cheyenne Wells's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.